Emily Craver

Ms. Emily Craver


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Samuel O AntwiSamuel O Antwi
Samuel O Antwi
ECEmily Craver
Emily Craver
YNYvonne Ayerki Nartey
Yvonne Ayerki Nartey
KSKurt Sartorius
Kurt Sartorius
TPTushar Patel
Tushar Patel
Non-alcoholic fatty liver disease (NAFLD) is a fast-growing public health problem and predisposes to hepatocellular carcinoma (HCC) in a significant proportion of patients. Metabolic alterations might underlie the progression of NAFLD to HCC, but the magnitudes of risk and population-attributable risk fractions (PAFs) for various metabolic conditions that are associated with HCC risk in patients with NAFLD are unknown. We investigated the associations between metabolic conditions and HCC development in individuals with a prior history of NAFLD. The study included 11,245 participants in the SEER-Medicare database, comprising 1310 NAFLD-related HCC cases and 9835 NAFLD controls. We excluded individuals with competing liver diseases (e.g., alcoholic liver disease and chronic viral hepatitis). Baseline pre-existing diabetes mellitus, dyslipidemia, obesity, hypertension, hypothyroidism, and metabolic syndrome were assessed. Multivariable-adjusted logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). PAFs were also calculated for each metabolic condition. The results show that diabetes (OR = 2.39, 95% CI: 2.04–2.79), metabolic syndrome (OR = 1.73, 95% CI: 1.49–2.01), and obesity (OR = 1.62, 95% CI: 1.43–1.85) were associated with a higher HCC risk in individuals with NAFLD. The highest PAF for HCC was observed for pre-existing diabetes (42.1%, 95% CI: 35.7–48.5), followed by metabolic syndrome (28.8%, 95% CI: 21.7–35.9) and obesity (13.2%, 95% CI: 9.6–16.8). The major predisposing factors for HCC in individuals with NAFLD are diabetes mellitus, metabolic syndrome, and obesity, and their control would be critically important in mitigating the rising incidence of NAFLD-related HCC.

16 November 2023 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
MIMadiha Iqbal
Madiha Iqbal
DJDeepa Jagadeesh
Deepa Jagadeesh
JCJulio Chavez
Julio Chavez
AKArushi Khurana
Arushi Khurana
ARAllison Rosenthal
Allison Rosenthal
MKMohamed A. Kharfan-Dabaja
Mohamed A. Kharfan-Dabaja

22 September 2023 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
DGDavid G. Gelikman
David G. Gelikman
KIKristen R. Ibanez
Kristen R. Ibanez
YGYasmine S. Ghattas
Yasmine S. Ghattas
ECEmily Craver
Emily Craver
ACAdela T. Casas-Melley
Adela T. Casas-Melley
ASAbhishek Seth
Abhishek Seth

1 December 2021 in Clinical Imaging
Verified
Journal Article
Closed access
SMSanto Maimone
Santo Maimone
AMAndrey P. Morozov
Andrey P. Morozov
ZLZhuo Li
Zhuo Li
ECEmily Craver
Emily Craver
EEErin A. Elder
Erin A. Elder
SMSarah A. McLaughlin
Sarah A. McLaughlin

19 August 2022 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
MMMichael Mohseni
Michael Mohseni
ECEmily Craver
Emily Craver
MHMichael G. Heckman
Michael G. Heckman
JSJohnathan Michael Sheele
Johnathan Michael Sheele
Introduction: Urinary tract infections (UTI) are one of the most common infections encountered in the emergency department (ED) with an estimated 2-3 million annual visits. Commonly prescribed antibiotics for UTIs have shown growing rates of resistance. Previous studies lack direction on improving UTI treatment based on the labs available to the bedside clinician. Methods: We sought to determine if antibiotic resistance in UTIs was related to demographics, urinalysis, and history of renal failure or kidney stones. We conducted an analysis of 892 women ≥18 years of age discharged from the ED with a UTI diagnosis. We assessed predictors of nitrofurantoin resistance, cefazolin resistance, ciprofloxacin resistance, and trimethoprim-sulfamethoxazole resistance using unadjusted and multivariable logistic regression models. Results: Antibiotic resistance was 13.6% for nitrofurantoin, 11.9% for cefazolin, 12.8% for ciprofloxacin, and 17.1% for trimethoprim-sulfamethoxazole. In multivariable analysis, significant independent associations with an increased likelihood of resistance to nitrofurantoin were observed for less urine blood (OR [per 1 category increase of score] 0.81; P = 0.02); greater mucous (OR [per 1 category increase of score] 1.22; P = 0.02); less specific gravity urine (OR [per 1 category increase] 0.87; P = 0.04), and presence of any history of kidney stones (OR 3.24; P = 0.01). There were no significant predictors for cefazolin resistance (all P ≥0.06); age was the only significant predictor of ciprofloxacin resistance (OR per 10 year increase] 1.10, P = 0.05), and lower specific gravity urine was significantly associated with an increased risk of resistance to trimethoprim- sulfamethoxazole (OR [per 1 category increase] 0.88, P = 0.04). Conclusion: Women with any history of kidney stones may have bacteriuria resistant to nitrofurantoin, suggesting that providers might consider alternative antibiotic therapies in this scenario.

12 August 2024 in Spine Deformity
Verified
Journal Article
Closed access
PDF file
KNKevin M. Neal
Kevin M. Neal
MBMelanie Boeyer
Melanie Boeyer
ECEmily Craver
Emily Craver
JCJulia E. Crook
Julia E. Crook
GKGary M. Kiebzak
Gary M. Kiebzak